Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.

BACKGROUND & AIMS Cancer cells undergo an epithelial-to-mesenchymal transition (EMT) to become invasive, allowing tumors to progress. However, there is no direct evidence that human cancer cells undergo an EMT. In mouse cancer cells, up-regulation of transcription factor Twist1 was shown to promote an EMT. We searched the stroma of human colorectal tumor samples for TWIST1-positive cells with a mesenchymal phenotype and neoplastic genotype. METHODS We measured the expression of TWIST1 in human colorectal cancer (CRC) cell lines and examined the effects of overexpression or knockdown in vitro and in mice. We used immunohistochemistry to measure levels of TWIST1 in 201 colorectal tumor samples. In 20 samples, immunostaining was combined with fluorescence in situ hybridization analyses. Levels of TWIST1 messenger RNA (mRNA) were measured in blood samples from 15 patients. RESULTS TWIST1 was required to maintain the mesenchymal phenotype and invasiveness of the microsatellite-stable CoLo741 cells (which express endogenous TWIST1) and SW480 (expressing transgenic TWIST1). TWIST1 mRNA was not translated in CRC cells with microsatellite instability (HCT116). Syngenic TWIST1-positive colon carcinoma cells (CT26) that invaded tissues surrounding tumors acquired a mesenchymal phenotype. The presence of TWIST1-positive cells in the stroma of human colorectal tumors correlated with microsatellite stability (P = .05), stage IV cancer (P = .02), and disease-free survival time (P < .01). Trisomies of chromosome 7 and/or chromosome 20 were detected in 17 of 20 colorectal tumor samples, each of which contained TWIST1-positive cells with matching chromosomal gains in the tumor stroma (86 of 776 counted cells; 11.1%). No trisomy was observed in TWIST1-negative stromal cells (0 of 1249 cells; P < .001). Levels of TWIST1 mRNA were significantly higher in blood samples from patients with CRC than controls. CONCLUSIONS The stroma of human colorectal tumors contains TWIST1-positive cancer cells with mesenchymal phenotypes. Patients with CRC have higher levels of TWIST1 mRNA than healthy individuals.

[1]  Lee Hoong-Chien,et al.  Supplementary Table 4 , 2015 .

[2]  Soile Tapio,et al.  Supplementary table 1 , 2014 .

[3]  Feng Li,et al.  Supplementary Table 7. , 2014 .

[4]  Mario Schelhaas,et al.  Supplementary Table 8 , 2014 .

[5]  W. Sellers,et al.  Twenty-fourth annual Pezcoller symposium: Molecular basis for resistance to targeted agents. , 2013, Cancer research.

[6]  E. Thompson,et al.  Cancer: The to and fro of tumour spread , 2013, Nature.

[7]  Klaus Pantel,et al.  Biologic challenges in the detection of circulating tumor cells. , 2013, Cancer research.

[8]  Michael Hummel,et al.  Supplementary Figure 3 , 2010 .

[9]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[10]  Jing Yang,et al.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. , 2012, Cancer cell.

[11]  Y. Toiyama,et al.  MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis , 2012, Gut.

[12]  J. Bastid.  EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations , 2012, Cancer and Metastasis Reviews.

[13]  Mario Schelhaas,et al.  Supplementary Table 5 , 2012 .

[14]  Valeria Panebianco,et al.  Supplementary Figure 2 , 2012 .

[15]  Varpu Marjomäki,et al.  Supplementary Table 6 , 2012 .

[16]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[17]  P. Muti,et al.  RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function , 2017, Cell Death & Disease.

[18]  G. Barrière,et al.  Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis , 2012, BMC Cancer.

[19]  Kornelia Polyak,et al.  Heterogeneity in breast cancer. , 2011, The Journal of clinical investigation.

[20]  Heidi Ledford.  Cancer theory faces doubts , 2011, Nature.

[21]  J. García,et al.  TWIST1 Is Expressed in Colorectal Carcinomas and Predicts Patient Survival , 2011, PloS one.

[22]  Thinzar M. Lwin,et al.  Twist1-induced invadopodia formation promotes tumor metastasis. , 2011, Cancer cell.

[23]  H. Urlaub,et al.  Supplementary Table 3 , 2011 .

[24]  E. Henske,et al.  Supplementary Figure 6 , 2011 .

[25]  E. Coccia,et al.  RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord , 2009, Nature Cell Biology.

[26]  A. Mannermaa,et al.  Transcription factors zeb1, twist and snai1 in breast carcinoma , 2011, BMC Cancer.

[27]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[28]  T. Shibata,et al.  p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast , 2010, Modern Pathology.

[29]  D. Park,et al.  Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. , 2010, Gastroenterology.

[30]  C. Baker,et al.  A metastatic colon cancer model using nonoperative transanal rectal injection , 2010, Surgical Endoscopy.

[31]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[32]  F. Portillo,et al.  The morphological and molecular features of the epithelial-to-mesenchymal transition , 2009, Nature Protocols.

[33]  I. Haviv,et al.  Clonal mutations in the cancer-associated fibroblasts: the case against genetic coevolution. , 2009, Cancer research.

[34]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[35]  F. Alameda,et al.  Snail1 Protein in the Stroma as a New Putative Prognosis Marker for Colon Tumours , 2009, PloS one.

[36]  Simone Brabletz,et al.  E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer , 2009, Cancer and Metastasis Reviews.

[37]  Jun Yao,et al.  Regulation of in situ to invasive breast carcinoma transition. , 2008, Cancer cell.

[38]  Kou-Juey Wu,et al.  Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.

[39]  E. Bandrés,et al.  TWIST1 Overexpression is Associated with Nodal Invasion and Male Sex in Primary Colorectal Cancer , 2008, Annals of Surgical Oncology.

[40]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[41]  P. Platzer,et al.  Breast-cancer stromal cells with TP53 mutations and nodal metastases. , 2007, The New England journal of medicine.

[42]  Edison T Liu,et al.  Stromal effects in breast cancer. , 2007, The New England journal of medicine.

[43]  V. Torri,et al.  Reduced Likelihood of Metastases in Patients with Microsatellite-Unstable Colorectal Cancer , 2007, Clinical Cancer Research.

[44]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[45]  Stephen C. Harris,et al.  Rat toxicogenomic study reveals analytical consistency across microarray platforms , 2006, Nature Biotechnology.

[46]  Y. Numata,et al.  Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas , 2005, Gut.

[47]  R. Lothe,et al.  The order of genetic events associated with colorectal cancer progression inferred from meta‐analysis of copy number changes , 2006, Genes, chromosomes & cancer.

[48]  D. Tarin,et al.  The fallacy of epithelial mesenchymal transition in neoplasia. , 2005, Cancer research.

[49]  E. Hay,et al.  The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[50]  J. Zavadil,et al.  TGF-beta and epithelial-to-mesenchymal transitions. , 2005, Oncogene.

[51]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[52]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[53]  Y. Tagawa,et al.  Gain of Chromosome 20 Is a Frequent Aberration in Liver Metastasis of Colorectal Cancers , 1997, Digestive Diseases and Sciences.

[54]  Mattias Höglund,et al.  Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenoma-carcinoma transition. , 2002, Cancer research.

[55]  I. Gitelman.  Twist protein in mouse embryogenesis. , 1997, Developmental biology.

[56]  T. Dingermann,et al.  Trisomy 7 in Short‐Term Cultures of Colorectal Adenocarcinomas , 1992, Genes, chromosomes & cancer.